Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03874923
Other study ID # PI2018_843_0034
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date August 2023

Study information

Verified date May 2023
Source Centre Hospitalier Universitaire, Amiens
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of fluid challenge is to increase oxygen delivery (DO2) in order to improve/restore tissue oxygen consumption (VO2). However the fluid challenge volume to administer stills in debate, some studies recommend to administer 250 mL. Previous studies suggested that 500 mL of fluid challenge administration may improve cardiac output and oxygen delivery. The relation between the amount of fluid expansion and oxygen delivery and oxygen consumption was not yet been studied in a randomized study in critical care patients. This is the purpose of this study.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 24
Est. completion date August 2023
Est. primary completion date May 24, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient for whom the physician in charge decided to infuse fluid challenge because of signs of acute circulatory failure (systolic arterial blood pressure < 90mmHg, and/or mean arterial blood pressure< 65 mmHg, and/or the need of vasopressive amine infusion, and/or skin mottling, and/or diuresis <0.5 mL/kg/h for more than 2 hours, and/or arterial lactate level>2mmol/L. - Echogenic patient - Patient with a Stroke Volume (SV) variation with passive leg raising (PLR) more than 10%. - Patient with regular sinus rhythm. - Patient who received protocol information. Exclusion Criteria: - Age Under 18-year-old. - Pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Fluid challenge
After randomisation, patient will receive 250 ml or 500 ml of fluid challenge. VO2 will be assessed before fluid challenge, immediately, 30 minutes and 60 minutes after fluid challenge.

Locations

Country Name City State
France CHU Amiens Picardie Amiens

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary VO2 after fluid challenge Tissue oxygen consumption (VO2) after fluid challenge 30 minutes after fluid challenge.
Primary VO2 after fluid challenge Tissue oxygen consumption (VO2) after fluid challenge 60 minutes after fluid challenge.
Secondary Change of arterial lactate concentration from baseline Baseline is the measurement of arterial lactate concentration immediately after fluid challenge 30 minutes after fluid challenge.
Secondary Change of arterial lactate concentration from baseline Baseline is the measurement of arterial lactate concentration immediately after fluid challenge 60 minutes after fluid challenge.
Secondary Respiratory variation of stroke volume Respiratory variation of stroke volume after fluid challenge. Immediately, 30 and 60 minutes after fluid challenge.
Secondary PaO2/FiO2 PaO2/FiO2 ratio (ratio of arterial oxygen partial pressure to fractional inspired oxygen) after fluid challenge Immediately, 30 and 60 minutes after fluid challenge.
Secondary Respiratory variation of the pulse pressure Respiratory variation of the pulse pressure 30 and 60 minutes after fluid challenge.
Secondary Stroke volume variation with passive leg raising (PLV) Stroke volume variation with passive leg raising (PLV) 30 and 60 minutes after fluid challenge.
Secondary Systolic heart function (LVEF) Systolic heart function (LVEF) Immediately, 30 and 60 minutes after fluid challenge.
Secondary Diastolic heart function Diastolic heart function (E, A, E', A', S' waves) Immediately, 30 and 60 minutes after fluid challenge.
See also
  Status Clinical Trial Phase
Recruiting NCT05114551 - ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure
Completed NCT05547646 - The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia
Recruiting NCT03697785 - Weaning Algorithm for Mechanical VEntilation N/A
Completed NCT02922101 - Evaluation of the Effectiveness of an Audit and Feedback Intervention With Quality Improvement Toolbox in Intensive Care N/A
Completed NCT02902783 - DONATE-Pilot Study on ICU Management of Deceased Organ Donors
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Completed NCT01857986 - Evaluating Air Leak Detection in Intubated Patients N/A
Recruiting NCT05518955 - VR Integrated Into Multicomponent Interventions for Improving Sleep in ICU N/A
Recruiting NCT03810768 - Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Completed NCT03295630 - Validity of an Actigraph Accelerometer Following Critical Illness N/A
Completed NCT05556811 - HEaling LIght Algorithms for the ICU Patient N/A
Recruiting NCT05702411 - Air Stacking Technique For Pulmonary Reexpansion N/A
Completed NCT02741453 - Bilateral Internal Jugular Veins Ultrasound Scanning Prior to CVC Placement N/A
Recruiting NCT04979897 - Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic
Completed NCT05281224 - Ventilator Tube Holder for Patients With a Tracheostomy
Withdrawn NCT02970903 - VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU N/A
Recruiting NCT02587273 - The Pharmacokinetics of Fentanyl in Intensive Care Patients Phase 4
Completed NCT02661607 - Point of Care Echocardiography Versus Chest Radiography for the Assessment of Central Venous Catheter Placement N/A
Completed NCT01479153 - Venous Site for Central Catheterization N/A
Recruiting NCT06110390 - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients N/A